(Q33234192)

24 July 2017

Oncolysis and suppression of tumor growth by a GFP-expressing oncolytic adenovirus controlled by an hTERT and CMV hybrid promoter (English)

1 reference

24 July 2017

1 reference

1 reference

J J Davis

1

1 reference

24 July 2017

L Wang

2

1 reference

24 July 2017

F Dong

3

1 reference

24 July 2017

L Zhang

4

1 reference

24 July 2017

W Guo

5

1 reference

24 July 2017

F Teraishi

6

1 reference

24 July 2017

K Xu

7

1 reference

24 July 2017

L Ji

8

1 reference

24 July 2017

B Fang

9

1 reference

24 July 2017

17 February 2006

1 reference

24 July 2017

1 reference

24 July 2017

13

1 reference

24 July 2017

720-723

1 reference

24 July 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700944

24 July 2017

0 references

cites work

Visualization of intrathoracically disseminated solid tumors in mice with optical imaging by telomerase-specific amplification of a transferred green fluorescent protein gene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617001

Antitumor synergy of CV787, a prostate cancer-specific adenovirus, and paclitaxel and docetaxel

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617001

Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617001

RGD inclusion in the hexon monomer provides adenovirus type 5-based vectors with a fiber knob-independent pathway for infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617001

E1B-55K-deleted adenovirus expressing E1A-13S by AFP-enhancer/promoter is capable of highly specific replication in AFP-producing hepatocellular carcinoma and eradication of established tumor.

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700944

A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617001

Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617001

Targeted expression of green fluorescent protein/tumor necrosis factor-related apoptosis-inducing ligand fusion protein from human telomerase reverse transcriptase promoter elicits antitumor activity without toxic effects on primary human hepatocytes

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16485010

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Late expression of p53 from a replicating adenovirus improves tumor cell killing and is more tumor cell specific than expression of the adenoviral death protein

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16485010

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/SJ.CGT.7700944

1 reference

24 July 2017

1 reference

24 July 2017

1 reference